We’re awarding scholarships on select certifications through March 31st. |  Qualify Now


9 New Introduction Codes Added to ICD-10-PCS

9 New Introduction Codes Added to ICD-10-PCS

Effective April 1, 2022, hospitals will have nine new procedure codes to describe the introduction or infusion of therapeutics, including the additional COVID-19 vaccines recently authorized for emergency use by the Food and Drug Administration.

April Update

The Centers for Medicare & Medicaid Services first introduced seven new ICD-10-PCS codes for second quarter 2022. The procedure codes are:

XW013V7 Introduction of COVID-19 vaccine dose 3 into subcutaneous tissue, percutaneous approach, new technology group 7

XW013W7 Introduction of COVID-19 vaccine booster into subcutaneous tissue, percutaneous approach, new technology group 7

XW023V7 Introduction of COVID-19 vaccine dose 3 into muscle, percutaneous approach, new technology group 7

XW023W7 Introduction of COVID-19 vaccine booster into muscle, percutaneous approach, new technology group 7

XW0DXR7 Introduction of fostamatinib into mouth and pharynx, external approach, new technology group 7

XW0G7R7 Introduction of fostamatinib into upper GI, via natural or artificial opening, new technology group 7

XW0H7R7 Introduction of fostamatinib into lower GI, via natural or artificial opening, new technology group 7

On Jan. 12, 2022, CMS added two new procedure codes:

XW023X7 Introduction of tixagevimab and cilgavimab monoclonal antibody into muscle, percutaneous approach, new technology group 7

XW023Y7 Introduction of other new technology monoclonal antibody into muscle, percutaneous approach, new technology group 7

These procedures are designated as non-operating room procedures, so there is no assigned Major Diagnosis Category (MDC) or Medicare Severity-Diagnosis Related Group (MS-DRG).

The updated code tables, index, and related addenda files for these new procedure codes are available on the CMS website.

COVID-19 Vaccine Billing Note

Make sure to use the appropriate CPT® codes for COVID-19 vaccines administered by injection to hospitalized patients to ensure proper reimbursement for the administration. Hospitals should not seek reimbursement for the COVID-19 vaccine product if it was supplied for free, and patients should not be billed for the COVID-19 vaccine at this time.

Renee Dustman
Follow me
Latest posts by Renee Dustman (see all)

About Has 763 Posts

Renee Dustman, BS, AAPC MACRA Proficient, is managing editor - content & editorial at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. Renee has more than 30 years' experience in journalistic reporting, print production, graphic design, and content management. Follow her on Twitter @dustman_aapc.

Leave a Reply

Your email address will not be published.